Highlights and Quick Summary
- Free Cash Flow Growth for the quarter ending September 30, 2023 was 55.43% (a 108.62% increase compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Growth increased by 120.49%
- Annual Free Cash Flow Growth for 2022 was 1.28% (a -100.2% decrease from previous year)
- Annual Free Cash Flow Growth for 2021 was -650.67% (a 669.66% increase from previous year)
- Annual Free Cash Flow Growth for 2020 was -84.54% (a -284.54% decrease from previous year)
- Twelve month Free Cash Flow Growth ending September 30, 2023 was 33.08% (a 44.64% increase compared to previous quarter)
- Twelve month trailing Free Cash Flow Growth increased by 2484.38% year-over-year
Trailing Free Cash Flow Growth for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| 33.08% | 22.87% | 20.6% | 1.28% |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Growth of Absci Corporation
Most recent Free Cash Flow Growthof ABSI including historical data for past 10 years.Interactive Chart of Free Cash Flow Growth of Absci Corporation
Absci Corporation Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 55.43% | 26.57% | 27.35% | – | – |
| 2022 | 25.14% | 12.62% | 17.94% | -105.19% | 1.28% |
| 2021 | -640.16% | -694.86% | -783.37% | -421.35% | -650.67% |
| 2020 | 51.82% | 87.42% | 88.68% | 80.82% | -84.54% |
| 2019 | -107.55% | – | – | – | 45.81% |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology